Follow the people · Insider
Gaurav Shah
Gaurav Shah files insider transactions with the SEC as a ceo of Rocket Pharmaceuticals (RCKT). We hold 7 disclosed purchases and sales filed since 2 April 2018, 2 of them in the last 90 days.
- Files forRCKT
- Disclosed buys and sells7 in all, 2 in the last 90 days
- Last disclosure20 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 29 March 2018 — 18 August 2026CEO · Rocket Pharmaceuticals (RCKT)90 Form 4 lines · source: SEC Form 4
- Filed 9 June 2022 — 13 June 2023Director · Talaris Therapeutics (TALS)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
92 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 2,293 shares of Rocket PharmaceuticalsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 2,837 shares of Rocket PharmaceuticalsSEC Form 417 August 2026Common Stock · traded 13 August 2026 · filed 17 August 2026
- exercised options over 76,490 shares of Rocket PharmaceuticalsSEC Form 426 May 2026Common Stock · traded 21 May 2026 · filed 26 May 2026
- ▼ sold on the open market 55,684 shares of Rocket PharmaceuticalsSEC Form 426 May 2026Common Stock · traded 21 May 2026 · filed 26 May 2026
- exercised options over 76,490 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 426 May 2026Stock Option (Right to Buy) · traded 21 May 2026 · filed 26 May 2026
- ▼ sold on the open market 2,409 shares of Rocket PharmaceuticalsSEC Form 421 May 2026Common Stock · traded 19 May 2026 · filed 21 May 2026
- ▼ sold on the open market 2,728 shares of Rocket PharmaceuticalsSEC Form 414 May 2026Common Stock · traded 13 May 2026 · filed 14 May 2026
- ▼ sold on the open market 5,990 shares of Rocket PharmaceuticalsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 5,990 shares of Rocket PharmaceuticalsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 12,279 shares of Rocket PharmaceuticalsSEC Form 418 February 2026Common Stock · traded 13 February 2026 · filed 18 February 2026
- ▼ sold on the open market 12,279 shares of Rocket PharmaceuticalsSEC Form 418 February 2026Common Stock · traded 13 February 2026 · filed 18 February 2026
- was granted 286,028 shares of Rocket PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 870,648 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Option (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 870,648 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Option (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 286,028 shares of Rocket PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- ▼ sold on the open market 6,276 shares of Rocket PharmaceuticalsSEC Form 420 November 2025Common Stock · traded 18 November 2025 · filed 20 November 2025
- had shares withheld for tax on 2,234 shares of Rocket PharmaceuticalsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- ▼ sold on the open market 2,253 shares of Rocket PharmaceuticalsSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
- ▼ sold on the open market 3,621 shares of Rocket PharmaceuticalsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▲ bought on the open market 20,000 shares of Rocket PharmaceuticalsSEC Form 414 April 2025Common Stock · traded 10 April 2025 · filed 14 April 2025
- ▼ sold on the open market 16,303 shares of Rocket PharmaceuticalsSEC Form 425 February 2025Common Stock · traded 21 February 2025 · filed 25 February 2025
- was granted 243,345 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2025Stock Option (Right to Buy) · traded 11 February 2025 · filed 13 February 2025
- was granted 81,655 shares of Rocket PharmaceuticalsSEC Form 413 February 2025Common Stock · traded 11 February 2025 · filed 13 February 2025
- ▼ sold on the open market 11,091 shares of Rocket PharmaceuticalsSEC Form 425 November 2024Common Stock · traded 21 November 2024 · filed 25 November 2024
- ▼ sold on the open market 9,650 shares of Rocket PharmaceuticalsSEC Form 420 August 2024Common Stock · traded 16 August 2024 · filed 20 August 2024
- exercised options over 7,979 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 14 May 2024 · filed 20 May 2024
- exercised options over 9,683 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 14 May 2024 · filed 20 May 2024
- acquired or disposed of, other 23,940 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 14 February 2022 · filed 20 May 2024
- acquired or disposed of, other 67,785 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 14 February 2023 · filed 20 May 2024
- exercised options over 7,979 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 14 May 2024 · filed 20 May 2024
- exercised options over 9,683 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 14 May 2024 · filed 20 May 2024
- acquired or disposed of, other 23,940 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 14 February 2022 · filed 20 May 2024
- acquired or disposed of, other 67,785 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 14 February 2023 · filed 20 May 2024
- ▼ sold on the open market 9,790 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 16 May 2024 · filed 20 May 2024
- was granted 196,336 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Stock Option (Right to Buy) · traded 16 February 2024 · filed 21 February 2024
- ▼ sold on the open market 20,272 shares of Rocket PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- was granted 66,577 shares of Rocket PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- exercised options over 7,979 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 14 February 2024 · filed 16 February 2024
- exercised options over 38,849 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 14 February 2024 · filed 16 February 2024
- exercised options over 46,828 shares of Rocket PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- exercised options over 7,979 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 November 2023Restricted Stock Units · traded 14 November 2023 · filed 16 November 2023
- exercised options over 7,979 shares of Rocket PharmaceuticalsSEC Form 416 November 2023Common Stock · traded 14 November 2023 · filed 16 November 2023
- ▼ sold on the open market 4,767 shares of Rocket PharmaceuticalsSEC Form 421 August 2023Common Stock · traded 17 August 2023 · filed 21 August 2023
- exercised options over 7,979 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 415 August 2023Restricted Stock Units · traded 14 August 2023 · filed 15 August 2023
- exercised options over 7,979 shares of Rocket PharmaceuticalsSEC Form 415 August 2023Common Stock · traded 14 August 2023 · filed 15 August 2023
- was granted 20,500 shares of Talaris Therapeutics (a derivative holding)SEC Form 414 June 2023Stock Option (Right to Buy) · traded 13 June 2023 · filed 14 June 2023
- ▼ sold on the open market 4,122 shares of Rocket PharmaceuticalsSEC Form 419 May 2023Common Stock · traded 17 May 2023 · filed 19 May 2023
- exercised options over 7,979 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 May 2023Restricted Stock Units · traded 14 May 2023 · filed 16 May 2023
- exercised options over 7,979 shares of Rocket PharmaceuticalsSEC Form 416 May 2023Common Stock · traded 14 May 2023 · filed 16 May 2023
- was granted 348,590 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 422 February 2023Stock Option (Right to Buy) · traded 14 February 2023 · filed 22 February 2023
- was granted 116,317 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 422 February 2023Restricted Stock Units · traded 14 February 2023 · filed 22 February 2023
- exercised options over 31,440 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 422 February 2023Restricted Stock Units · traded 14 February 2023 · filed 22 February 2023
- exercised options over 31,440 shares of Rocket PharmaceuticalsSEC Form 422 February 2023Common Stock · traded 14 February 2023 · filed 22 February 2023
- ▼ sold on the open market 12,194 shares of Rocket PharmaceuticalsSEC Form 422 February 2023Common Stock · traded 17 February 2023 · filed 22 February 2023
- was granted 348,590 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2023Stock Option (Right to Buy) · traded 14 February 2023 · filed 16 February 2023
- was granted 116,317 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2023Restricted Stock Units · traded 14 February 2023 · filed 16 February 2023
- was granted 14,501 shares of Talaris Therapeutics (a derivative holding)SEC Form 413 June 2022Stock Option (Right to Buy) · traded 9 June 2022 · filed 13 June 2022
- was granted 297,037 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2022Stock Option (Right to Buy) · traded 14 February 2022 · filed 16 February 2022
- was granted 95,275 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2022Restricted Stock Units · traded 14 February 2022 · filed 16 February 2022
- ▲ bought on the open market 22,000 shares of Rocket PharmaceuticalsSEC Form 48 February 2022Common Stock · traded 7 February 2022 · filed 8 February 2022
- had shares withheld for tax on 19,984 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- had shares withheld for tax on 8,667 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- had shares withheld for tax on 48,732 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- had shares withheld for tax on 8,505 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- exercised options over 75,880 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- had shares withheld for tax on 3,000 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- had shares withheld for tax on 61,350 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- had shares withheld for tax on 23,003 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- exercised options over 75,880 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 41 April 2021Stock Option (Right to Buy) · traded 31 March 2021 · filed 1 April 2021
- had shares withheld for tax on 7,493 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- had shares withheld for tax on 5,919 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 1 April 2021 · filed 1 April 2021
- had shares withheld for tax on 8,872 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 1 April 2021 · filed 1 April 2021
- had shares withheld for tax on 7,475 shares of Rocket PharmaceuticalsSEC Form 41 April 2021Common Stock · traded 1 April 2021 · filed 1 April 2021
- gave away 207,897 shares of Rocket PharmaceuticalsSEC Form 416 February 2021Common Stock · traded 9 December 2020 · filed 16 February 2021
- gave away 207,897 shares of Rocket PharmaceuticalsSEC Form 416 February 2021Common Stock · traded 9 December 2020 · filed 16 February 2021
- gave away 126,341 shares of Rocket PharmaceuticalsSEC Form 416 February 2021Common Stock · traded 18 December 2020 · filed 16 February 2021
- gave away 126,341 shares of Rocket PharmaceuticalsSEC Form 416 February 2021Common Stock · traded 18 December 2020 · filed 16 February 2021
- gave away 72,000 shares of Rocket PharmaceuticalsSEC Form 416 February 2021Common Stock · traded 31 December 2020 · filed 16 February 2021
- gave away 72,000 shares of Rocket PharmaceuticalsSEC Form 416 February 2021Common Stock · traded 31 December 2020 · filed 16 February 2021
- was granted 185,000 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 48 February 2021Stock Option (Right to Buy) · traded 4 February 2021 · filed 8 February 2021
- exercised options over 90,925 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 426 March 2020Stock Option (Right to Buy) · traded 24 March 2020 · filed 26 March 2020
- exercised options over 90,925 shares of Rocket PharmaceuticalsSEC Form 426 March 2020Common Stock · traded 24 March 2020 · filed 26 March 2020
- had shares withheld for tax on 32,645 shares of Rocket PharmaceuticalsSEC Form 426 March 2020Common Stock · traded 24 March 2020 · filed 26 March 2020
- exercised options over 290,000 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 427 February 2020Stock Option (Right to Buy) · traded 25 February 2020 · filed 27 February 2020
- exercised options over 290,000 shares of Rocket PharmaceuticalsSEC Form 427 February 2020Common Stock · traded 25 February 2020 · filed 27 February 2020
- had shares withheld for tax on 6,233 shares of Rocket PharmaceuticalsSEC Form 427 February 2020Common Stock · traded 25 February 2020 · filed 27 February 2020
- was granted 383,306 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 410 February 2020Stock Option (Right to Buy) · traded 6 February 2020 · filed 10 February 2020
- ▼ sold on the open market 25,000 shares of Rocket PharmaceuticalsSEC Form 45 March 2019Common Stock · traded 1 March 2019 · filed 5 March 2019
- ▼ sold on the open market 24,900 shares of Rocket PharmaceuticalsSEC Form 45 March 2019Common Stock · traded 4 March 2019 · filed 5 March 2019
- ▼ sold on the open market 25,000 shares of Rocket PharmaceuticalsSEC Form 45 March 2019Common Stock · traded 5 March 2019 · filed 5 March 2019
- was granted 315,700 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 430 January 2019Stock Option (Right to Buy) · traded 28 January 2019 · filed 30 January 2019
- was granted 395,000 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 42 April 2018Stock Option (Right to Buy) · traded 29 March 2018 · filed 2 April 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.